Reata Pharmaceuticals (NASDAQ:RETA) reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Reata Pharmaceuticals beat estimated earnings by 32.67%, reporting an EPS of $-1.36 versus an estimate of $-2.02.

Revenue was down $1.46 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.82 which was followed by a 7.0% drop in the share price the next day.

Here's a look at Reata Pharmaceuticals's past performance:

To track all earnings releases for Reata Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.